Related Experiment Video

Updated: May 15, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Treatment options for C3 glomerulopathy

Carla M Nester1, Richard J Smith

  • 1Departments of Internal Medicine and Pediatrics, University of Iowa, Iowa City, Iowa, USA. carla-nester@uiowa.edu

Current Opinion in Nephrology and Hypertension
|January 16, 2013
PubMed

Insights

C3 glomerulopathy (C3G) shows limited response to traditional treatments. Emerging research suggests terminal complement blockade, like eculizumab, may offer therapeutic benefits for this complement-mediated renal disease.

Area of Science:

  • Nephrology
  • Immunology
  • Complement System

Background:

  • C3 glomerulopathy (C3G) is a rare kidney disease characterized by complement deposition.
  • Understanding the alternative complement pathway's role is crucial for C3G pathogenesis.

Observation:

  • Traditional immunosuppression and plasma therapy demonstrate limited efficacy in C3G.
  • Emerging data suggests eculizumab, an anticomplement drug, may benefit some C3G patients.

Findings:

  • C3G exhibits minimal responsiveness to conventional immunosuppressive therapies.
  • Randomized controlled trials supporting C3G therapies are currently absent.
  • Animal studies and case reports indicate terminal complement blockade may be advantageous.

Implications:

  • Further research is needed to validate pathogenic mechanisms and disease spectrum in C3G.
  • Genetic and biomarker research are essential for guiding rigorous clinical trials.
  • Identifying effective therapies for C3G requires a deeper understanding of complement-mediated renal disease.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...